KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.

 

KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 

 

More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • 29/02/2016

    KNCV welcomes Worldwide Access Plan for Delamanid

    In Bangkok on Wednesday, 24 February, Lucica Diutu, Chair of the Stop TB Partnership, and Rajesh Gupta, Senior Director at…

    Lees meer
  • 10/02/2016

    ‘HEALTH FOR SALE’ – Dutch Leadership on Access to Affordable Medicines and Innovation

    On February 5, Aids Fonds, Médecins Sans Frontières (MSF), Drugs for Neglected Diseases initiative…

    Lees meer
  • 09/02/2016

    USAID-supported TB Call to Action awarded to REACH

    REACH, KNCV’s NGO partner in Chennai, India and currently implementing the Eli Lilly Private…

    Lees meer
  • 05/02/2016

    Jubilee for Netty Kamp

    During the February international meeting week, we congratulated senior consultant Netty Kamp with 12½…

    Lees meer
  • 04/02/2016

    KNCV welcomes Diana Numan

    This week Diana Numan joined KNCV as the new Director of the Operations Division.

    Lees meer
  • This is Keshia, 8 years old

    Tuberculosis is not always easy to diagnose in children. Keshia was lucky that her father recognized his daughter’s symptoms.

    Lees meer
  • Kazakhstan – New public-private partnerships in TB control

    KNCV Tuberculosis Foundation has had an active role in TB control in Kazakhstan for many years, through various projects funded…

    Lees meer
  • 01/02/2016

    Start of KNCV’s International Meeting Week

    KNCV central office is buzzing with activity this week, as we welcome staff from across the globe for five intensive…

    Lees meer
  • Innovation to impact – Introducing new drugs and shorter drug regimens

    Photo: Pharmacovigilance workshop, Tajikistan, December 2015. Current treatment of multidrug-resistant forms of TB (MDR-TB) requires the use of multiple…

    Lees meer
  • 15/01/2016

    Panel debate: From Innovation to Impact

    On January 26, KIT and KNCV hosted the panel debate ‘From Innovation to Impact’. Guest speakers included Mr. Hans Rosling…

    Lees meer
  • 12/01/2016

    Nigeria Minister of Health reaffirms support to KNCV/Challenge TB

    Our support to TB control in Nigeria is the largest KNCV/Challenge TB project in Africa. The Honorable Minister of Health,…

    Lees meer
  • National Implementation of GxAlert in Botswana – integrated patient data management

    TB data management through the GxAlert initiative Integrated patient data management through the GxAlert initiative KNCV has supported the national…

    Lees meer
  • 07/01/2016

    Launch of the US National Action Plan for Combating MDR-TB

    On January 7, USAID will officially launch the Obama Administration’s National Action Plan for Combating Multidrug-Resistant Tuberculosis (MDR-TB). On December…

    Lees meer
  • 18/12/2015

    Further decline of TB in the Netherlands in 2014.

    last century TB house – Zonnestraal The latest data on tuberculosis in the Netherlands in 2014 have been published…

    Lees meer
  • 03/12/2015

    Union 2015: Launch of self-assessment benchmarking tool for Childhood TB

    On Thursday 3 December, KNCV presented its Benchmarking tool for Childhood TB policies, practice and planning to the…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.